Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 406 of 1,261
  1. US 10738004

    Cyclic compound

    Takeda Pharmaceutical Company Limited · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  2. US 10736989

    Methods and compositions for stabilizing the myocardium

    The Regents of the University of California · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  3. US 10736964

    Immunomagnetic nanocapsule and kit for treating cancer

    China Medical University · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  4. US 10736915

    Nylon-3 co-polymers and synthetic lung surfactant compositions containing same

    Northwestern University · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  5. US 10736894

    Methods of treating developmental syndromes with PDE10A inhibitors

    OVID THERAPEUTICS INC. · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  6. US 10736969

    Multi-arm polymeric prodrug conjugates of pemetrexed-based compounds

    Nektar Therapeutics · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  7. US 10736961

    Method of averting opioid addiction

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  8. US 10738313

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  9. US 10738275

    Paenibacillus sp. strain, cultivation method and use of the same

    BRIGHT DAIRY & FOOD CO., LTD. · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  10. US 10736859

    Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride

    TONIX PHARMA LIMITED · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  11. US 10736857

    Treatment of pervasive developmental disorders with redox-active therapeutics

    PTC THERAPEUTICS, INC. · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  12. US 10736919

    Materials and methods for engineering cells and uses thereof in immuno-oncology

    CRISPR THERAPEUTICS AG · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  13. US 10736975

    Infusion administration of conjugated monoclonal antibodies

    Actinium Phamaceuticals, Inc. · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  14. US 10738312

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  15. US 10738305

    Materials and methods for treatment of hemoglobinopathies

    Vertex Pharmaceuticals Incorporated · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  16. US 10736880

    Therapeutics for preterm labor management

    The Board of Regents of the University of Texas System · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  17. US 10738123

    Anti-FLT-1 antibodies in treating bronchopulmonary dysplasia

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  18. US 10738113

    Anti-IL-2 antibodies and compositions and uses thereof

    The Regents of the University of California · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  19. US 10736875

    Methods and compositions associated with the granulocyte colony-stimulating factor receptor

    Ligand Pharmaceuticals Incorporated · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  20. US 10738112

    Anti-human interleukin-17A monoclonal antibody

    SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD. · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  21. US 10737113

    Human antibodies to PD-1

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  22. US 10738043

    GLS1 inhibitors for treating disease

    The Board of Regents of the University of Texas System · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  23. US 10738035

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  24. US 10729815

    Combined treatment for nerve injuries

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.